Clinical characterization, treatment, and outcome of nivolumab-induced bullous pemphigoid
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical characterization, treatment, and outcome of nivolumab-induced bullous pemphigoid
Authors
Keywords
-
Journal
INVESTIGATIONAL NEW DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-09-29
DOI
10.1007/s10637-023-01397-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Two rare cases of bullous pemphigoid associated with immune checkpoint inhibitors
- (2022) Anika Mazumder et al. BMJ Case Reports
- IgM pemphigoid
- (2021) Katharina Boch et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment‐resistant bullous pemphigoid developing during therapy with immune checkpoint inhibitors
- (2021) E. Povilaityte et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features
- (2020) Samantha Ellis et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Bullous pemphigoid
- (2019) Denise Miyamoto et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients
- (2019) Daan P. Hurkmans et al. Journal for ImmunoTherapy of Cancer
- Bullous pemphigoid in a patient treated with nivolumab
- (2019) Carlos Cuenca‐Barrales et al. Dermatologic Therapy
- A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors
- (2018) Adriana T. Lopez et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy
- (2018) Jacob Siegel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: IsHLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?
- (2017) K. T. Amber et al. HLA
- Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology
- (2015) C. Feliciani et al. BRITISH JOURNAL OF DERMATOLOGY
- In vivo analysis of IgE autoantibodies in bullous pemphigoid: A study of 100 cases
- (2015) Reine Moriuchi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis
- (2012) T. Krenacs et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Clinical Features and Practical Diagnosis of Bullous Pemphigoid
- (2011) Enno Schmidt et al. DERMATOLOGIC CLINICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started